-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 26, 2021, the team of Professor Yin Yuxin from the Institute of Systems Biomedicine of Peking University and the Joint Center for Life Sciences published an online publication titled "PTENɑ functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer" in Nature Communications.
The research paper, for the first time, described the molecular mechanism of PTENɑ, a member of the PTEN family, that promotes tumor immune escape by reducing the sensitivity of tumor cells to host immune attacks
.
The anti-cancer gene PTEN has high frequency mutations in many tumors
In summary, as an important immunosuppressive factor, phosphatase PTENα can limit the host's immune surveillance function and promote tumor immune escape
.
The specific targeting of the PTENα pathway can increase the sensitivity of tumor cells to immune killing
Related link: https://